Shopping Cart 0
Cart Subtotal
USD 0

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, "Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018" provides an overview of Opioid-Induced Constipation (OIC) clinical trials scenario. This report provides top line data relating to the clinical trials on Opioid-Induced Constipation (OIC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials 28

Prominent Drugs 29

Clinical Trial Profile Snapshots 30

Appendix 117

Abbreviations 117

Definitions 117

Research Methodology 118

Secondary Research 118

About GlobalData 119

Contact Us 119

Source 119


List Of Figure

List of Figures

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, G7 Countries (%), 2018* 15

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, E7 Countries (%), 2018* 18

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25

Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

GlobalData Methodology 118


List Of Table

List of Tables

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region, 2018* 7

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries, 2018* 12

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, G7 Countries (%), 2018* 15

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, E7 Countries (%), 2018* 18

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase, 2018* 21

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25

Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Valeant Pharmaceuticals International Inc AstraZeneca Plc Shionogi & Co Ltd Mundipharma International Ltd IQVIA Holdings Inc Merck & Co Inc Theravance Biopharma Inc Progenics Pharmaceuticals Inc Astorg Partners Alkermes Plc

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018

Summary

GlobalData's clinical trial report, "Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2018" provides an overview of Opioid-Induced Constipation (OIC) clinical trials scenario. This report provides top line data relating to the clinical trials on Opioid-Induced Constipation (OIC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials 28

Prominent Drugs 29

Clinical Trial Profile Snapshots 30

Appendix 117

Abbreviations 117

Definitions 117

Research Methodology 118

Secondary Research 118

About GlobalData 119

Contact Us 119

Source 119


List Of Figure

List of Figures

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, G7 Countries (%), 2018* 15

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, E7 Countries (%), 2018* 18

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25

Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

GlobalData Methodology 118


List Of Table

List of Tables

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region, 2018* 7

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries, 2018* 12

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, G7 Countries (%), 2018* 15

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

Proportion of Opioid-Induced Constipation (OIC) to Toxicology Clinical Trials, E7 Countries (%), 2018* 18

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19

Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase, 2018* 21

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22

Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25

Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28

Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Valeant Pharmaceuticals International Inc AstraZeneca Plc Shionogi & Co Ltd Mundipharma International Ltd IQVIA Holdings Inc Merck & Co Inc Theravance Biopharma Inc Progenics Pharmaceuticals Inc Astorg Partners Alkermes Plc